Abstract

Editorial Comment to Efficacy and safety of pembrolizumab and axitinib as first-line treatment for patients with advanced renal cell carcinoma: Real-world experience in Japan.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1 data from the KEYNOTE-659 phase IIb study
Akihito Kawazoe ...
European Journal of Cancer | VOL. 129
Akihito Kawazoe, et. al.Akihito Kawazoe ...
04 Mar 2020
ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma
T Powles ... G De Velasco
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 32
T Powles, et. al.T Powles ... G De Velasco
28 Sep 2021
Efficacy and safety of pembrolizumab and axitinib as first-line treatment for patients with advanced renal cell carcinoma: Real-world experience in Japan.
Ken‐Ichi Harada ... Asuka Sano
International journal of urology : official journal of the Japanese Urological Association | VOL. 30
Ken‐Ichi Harada, et. al.Ken‐Ichi Harada ... Asuka Sano
22 Jun 2023
Abstract S5-07: Preliminary efficacy and safety of pembrolizumab (MK-3475) in patients with PD-L1–positive, estrogen receptor-positive (ER+)/HER2-negative advanced breast cancer enrolled in KEYNOTE-028
Hs Rugo ... V Karantza
American Journal of Cancer | VOL. 76
Hs Rugo, et. al.Hs Rugo ... V Karantza
15 Feb 2016
View more papers

More From: International journal of urology : official journal of the Japanese Urological Association

Paper Title
Journal
Date
Author
Clinical characteristics and predictors of long-term postoperative urinary incontinence in patients treated with robot-assisted radical prostatectomy: A propensity-matched analysis.
Yuki Kohada ... Nobuyuki Hinata
International journal of urology : official journal of the Japanese Urological Association | VOL. -
Yuki Kohada, et. al.Yuki Kohada ... Nobuyuki Hinata
17 Jul 2024
Significance of androgen-deprivation therapy for intermediate- and high-risk prostate cancer treated with high-dose radiotherapy: A literature review.
Rihito Aizawa ...
International journal of urology : official journal of the Japanese Urological Association | VOL. -
Rihito Aizawa, et. al.Rihito Aizawa ...
17 Jul 2024
Sarcopenia as a predictor of mortality in kidney transplant recipients: A 5-year prospective cohort study with propensity score matching.
Akihiro Kosoku ... Junji Uchida
International journal of urology : official journal of the Japanese Urological Association | VOL. -
Akihiro Kosoku, et. al.Akihiro Kosoku ... Junji Uchida
16 Jul 2024
Editorial Comment to "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer".
Eiji Kikuchi ... Nozomi Hayakawa
International journal of urology : official journal of the Japanese Urological Association | VOL. -
Eiji Kikuchi, et. al.Eiji Kikuchi ... Nozomi Hayakawa
16 Jul 2024
View more papers